Every AI newsletter, investors ask questions on the investor interaction platform: Hello, secretary, when will the production license of Mingde Xinjiang be approved? thank you.
Wuhan Easy Diagnosis Biomedicine Co.Ltd(002932) (002932. SZ) said on the investor interaction platform on January 17 that Mingde Xinjiang Biotechnology Co., Ltd., the holding subsidiary of the company, is applying to the competent department for the production license of nucleic acid detection reagents.
